PGD2

Pgd2 is a lipid of Fatty Acyls (FA) class. Pgd2 is associated with abnormalities such as Inflammatory disorder, Pleurisy, Rhinitis, Dehydration and Pneumonia. The involved functions are known as antagonists, fat cell differentiation, Phosphorylation, Process and Gene Expression. Pgd2 often locates in Cell surface, Body tissue, Extracellular, Bone Marrow and Membrane. The associated genes with PGD2 are oxytocin, 1-desamino-(O-Et-Tyr)(2)-, P4HTM gene, PTGS2 gene, PTGDS gene and IL3 gene. The related lipids are 15-deoxyprostaglandin J2, Nonesterified Fatty Acids, Lipopolysaccharides, Steroids and Liposomes. The related experimental models are Knock-out and Rodent Model.

Cross Reference

Introduction

To understand associated biological information of PGD2, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with PGD2?

PGD2 is suspected in Asthma, Dehydration, Allergic rhinitis NOS, Rhinitis, Infertility, Pneumonia and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with PGD2

MeSH term MeSH ID Detail
Persistent Fetal Circulation Syndrome D010547 1 associated lipids
Zollinger-Ellison Syndrome D015043 1 associated lipids
Mastocytosis, Systemic D034721 1 associated lipids
Anal Gland Neoplasms D000694 1 associated lipids
Trigeminal Neuralgia D014277 1 associated lipids
Pulmonary Aspergillosis D055732 1 associated lipids
Optic Neuropathy, Ischemic D018917 2 associated lipids
Choroid Diseases D015862 2 associated lipids
Angioedemas, Hereditary D054179 2 associated lipids
Epilepsy, Tonic-Clonic D004830 2 associated lipids
Cryptorchidism D003456 2 associated lipids
Cystitis, Interstitial D018856 2 associated lipids
Decapitation D049248 2 associated lipids
Asthma, Aspirin-Induced D055963 2 associated lipids
Wounds, Stab D014951 3 associated lipids
Graves Ophthalmopathy D049970 3 associated lipids
Cryptococcosis D003453 3 associated lipids
Cholangitis D002761 3 associated lipids
Dirofilariasis D004184 3 associated lipids
Leukemia, B-Cell D015448 3 associated lipids
Airway Remodeling D056151 3 associated lipids
HTLV-I Infections D015490 3 associated lipids
Respiratory Sounds D012135 3 associated lipids
Ascariasis D001196 3 associated lipids
Sleep Disorders, Circadian Rhythm D020178 3 associated lipids
Idiopathic Pulmonary Fibrosis D054990 4 associated lipids
Goiter D006042 4 associated lipids
Headache D006261 4 associated lipids
Actinobacillus Infections D000189 4 associated lipids
Urticaria Pigmentosa D014582 4 associated lipids
Meningoencephalitis D008590 4 associated lipids
Coronavirus Infections D018352 4 associated lipids
Nasal Obstruction D015508 4 associated lipids
Muscular Dystrophy, Animal D009137 5 associated lipids
Vasculitis, Leukocytoclastic, Cutaneous D018366 5 associated lipids
Hematoma D006406 5 associated lipids
Myeloproliferative Disorders D009196 5 associated lipids
Fetal Alcohol Spectrum Disorders D063647 6 associated lipids
Xeroderma Pigmentosum D014983 6 associated lipids
Sneezing D012912 6 associated lipids
Hyperlipoproteinemia Type IV D006953 6 associated lipids
Tauopathies D024801 6 associated lipids
Rhinitis, Allergic, Perennial D012221 6 associated lipids
Thrombophilia D019851 6 associated lipids
Brain Damage, Chronic D001925 6 associated lipids
Leukodystrophy, Globoid Cell D007965 6 associated lipids
Rhinitis, Allergic, Seasonal D006255 7 associated lipids
Leukemia, Megakaryoblastic, Acute D007947 7 associated lipids
Folliculitis D005499 7 associated lipids
Multiple Sclerosis, Relapsing-Remitting D020529 7 associated lipids
Per page 10 20 50 100 | Total 189

PubChem Associated disorders and diseases

What pathways are associated with PGD2

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with PGD2?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with PGD2?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with PGD2?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with PGD2?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with PGD2?

Knock-out

Knock-out are used in the study 'Multiple roles of the prostaglandin D2 signaling pathway in reproduction.' (Rossitto M et al., 2015).

Rodent Model

Rodent Model are used in the study 'PKA regulatory IIα subunit is essential for PGD2-mediated resolution of inflammation.' (Kong D et al., 2016).

Related references are published most in these journals:

Model Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

NCBI Entrez Crosslinks

All references with PGD2

Download all related citations
Per page 10 20 50 100 | Total 3138
Authors Title Published Journal PubMed Link
Kim YI et al. Effects of 15-deoxy-∆¹²,¹⁴-prostaglandin J₂ on the production of IL-8 and the expression of Toll-like receptor 2 in human primary keratinocytes stimulated with lipopolysaccharide. 2011 Mol. Biol. Rep. pmid:20174873
Mor A et al. Inhibitory effect of farnesylthiosalicylic acid on mediators release by mast cells: preferential inhibition of prostaglandin D(2) and tumor necrosis factor-α release. 2011 Inflammation pmid:20706780
Balzar S et al. Mast cell phenotype, location, and activation in severe asthma. Data from the Severe Asthma Research Program. 2011 Am. J. Respir. Crit. Care Med. pmid:20813890
Mathurin K et al. An interaction between L-prostaglandin D synthase and arrestin increases PGD2 production. 2011 J. Biol. Chem. pmid:21112970
Wingard CJ et al. Mast cells contribute to altered vascular reactivity and ischemia-reperfusion injury following cerium oxide nanoparticle instillation. 2011 Nanotoxicology pmid:21043986
Joachim A and Ruttkowski B Prostaglandin D(2) synthesis in Oesophagostomum dentatum is mediated by cytosolic glutathione S-transferase. 2011 Exp. Parasitol. pmid:21056037
Lotz C et al. Peroxisome-proliferator-activated receptor γ mediates the second window of anaesthetic-induced preconditioning. 2011 Exp. Physiol. pmid:21123361
Tsujita T et al. Nitro-fatty acids and cyclopentenone prostaglandins share strategies to activate the Keap1-Nrf2 system: a study using green fluorescent protein transgenic zebrafish. 2011 Genes Cells pmid:21143560
Neri T et al. Role of NF-kappaB and PPAR-gamma in lung inflammation induced by monocyte-derived microparticles. 2011 Eur. Respir. J. pmid:21148223
Kumar VB et al. Angiogenic effect of laminin involves modulation of cyclooxygenase-2 and prostaglandin levels. 2011 Exp. Biol. Med. (Maywood) pmid:21148739
Chowdhury AA et al. 15-Deoxy-Δ(12,14)-prostaglandin J(2) interferes inducible synthesis of prostaglandins E(2) and F(2α) that suppress subsequent adipogenesis program in cultured preadipocytes. 2011 Prostaglandins Other Lipid Mediat. pmid:21699992
Yamamoto Y et al. Dual functions of prostaglandin D2 in murine contact hypersensitivity via DP and CRTH2. 2011 Am. J. Pathol. pmid:21703412
Ulivi V et al. Anti-inflammatory activity of monogalactosyldiacylglycerol in human articular cartilage in vitro: activation of an anti-inflammatory cyclooxygenase-2 (COX-2) pathway. 2011 Arthritis Res. Ther. pmid:21682897
Farhat A et al. Hematopoietic-Prostaglandin D2 synthase through PGD2 production is involved in the adult ovarian physiology. 2011 J Ovarian Res pmid:21352547
Yamamoto Y et al. 15-Deoxy-Δ12,14-prostaglandin J2 enhanced the anti-tumor activity of camptothecin against renal cell carcinoma independently of topoisomerase-II and PPARγ pathways. 2011 Biochem. Biophys. Res. Commun. pmid:21683069
Luker T et al. Zwitterionic CRTh2 antagonists. 2011 J. Med. Chem. pmid:21355602
Ayoub SS et al. Cyclooxygenase expression and prostaglandin levels in central nervous system tissues during the course of chronic relapsing experimental autoimmune encephalomyelitis (EAE). 2011 Inflamm. Res. pmid:21667309
Matsumoto T et al. Lipocalin-type prostaglandin D synthase is associated with coronary vasospasm and vasomotor reactivity in response to acetylcholine. 2011 Circ. J. pmid:21325722
Cha B et al. 15-deoxy-D12,14-prostaglandin J2 suppresses RANTES expression by inhibiting NADPH oxidase activation in Helicobacter pylori-infected gastric epithelial cells. 2011 J. Physiol. Pharmacol. pmid:21673364
Wang P et al. Interleukin-6 synthesis in human chondrocytes is regulated via the antagonistic actions of prostaglandin (PG)E2 and 15-deoxy-Δ(12,14)-PGJ2. 2011 PLoS ONE pmid:22096605
Maekawa N et al. High-performance affinity purification for identification of 15-deoxy-Δ 12,14 -PGJ₂ interacting factors using magnetic nanobeads. 2011 Biomed. Chromatogr. pmid:21374648
Kane CJ et al. Protection of neurons and microglia against ethanol in a mouse model of fetal alcohol spectrum disorders by peroxisome proliferator-activated receptor-γ agonists. 2011 Brain Behav. Immun. pmid:21376806
Arima M and Fukuda T Prostaglandin Dâ‚‚ and T(H)2 inflammation in the pathogenesis of bronchial asthma. 2011 Korean J. Intern. Med. pmid:21437156
Luna-Gomes T et al. Eosinophils as a novel cell source of prostaglandin D2: autocrine role in allergic inflammation. 2011 J. Immunol. pmid:22102725
Martínez-Gras I et al. The anti-inflammatory prostaglandin 15d-PGJ2 and its nuclear receptor PPARgamma are decreased in schizophrenia. 2011 Schizophr. Res. pmid:21334179
Zhao J et al. Age-related increases in PGD(2) expression impair respiratory DC migration, resulting in diminished T cell responses upon respiratory virus infection in mice. 2011 J. Clin. Invest. pmid:22105170
Chbicheb S et al. EGR1 expression: a calcium and ERK1/2 mediated PPARγ-independent event involved in the antiproliferative effect of 15-deoxy-Δ12,14-prostaglandin J2 and thiazolidinediones in breast cancer cells. 2011 Biochem. Pharmacol. pmid:21338579
Braciale TJ and Kim TS Slowing down with age: lung DCs do it too. 2011 J. Clin. Invest. pmid:22105176
Qiu Z et al. Cough reflex sensitivity and airway inflammation in patients with chronic cough due to non-acid gastro-oesophageal reflux. 2011 Respirology pmid:21342332
Wang JJ and Mak OT Induction of apoptosis by 15d-PGJ2 via ROS formation: an alternative pathway without PPARγ activation in non-small cell lung carcinoma A549 cells. 2011 Prostaglandins Other Lipid Mediat. pmid:21396480
Murata T et al. Prostagladin D2 is a mast cell-derived antiangiogenic factor in lung carcinoma. 2011 Proc. Natl. Acad. Sci. U.S.A. pmid:22106279
Yamamoto Y et al. Proteomic identification of protein targets for 15-deoxy-Δ(12,14)-prostaglandin J2 in neuronal plasma membrane. 2011 PLoS ONE pmid:21445266
Mackay GA and Stewart AG R2D(2) for C(4)Eo: an 'alliance' of PGD(2) receptors is required for LTC(4) production by human eosinophils. 2011 Br. J. Pharmacol. pmid:21426314
Huang ZL et al. The role of adenosine in the regulation of sleep. 2011 Curr Top Med Chem pmid:21401496
Osanai T and Okumura K Lipocalin-type PGD synthase as a novel biomarker for coronary vasospasm. 2011 Circ. J. pmid:21378446
Du H et al. Inhibition of COX-2 expression by endocannabinoid 2-arachidonoylglycerol is mediated via PPAR-γ. 2011 Br. J. Pharmacol. pmid:21501147
Varma D et al. Comparison of UHPLC and HPLC methods for the assay of prostanoids: "are the methods equivalent in terms of accuracy and precision?". 2011 Bioanalysis pmid:21510759
Kamauchi S and Urade Y [Hematopoietic prostaglandin D synthase inhibitors for the treatment of duchenne muscular dystrophy]. 2011 Brain Nerve pmid:22068479
Flachs P et al. Synergistic induction of lipid catabolism and anti-inflammatory lipids in white fat of dietary obese mice in response to calorie restriction and n-3 fatty acids. 2011 Diabetologia pmid:21779874
Raman P et al. 15-Deoxy-delta12,14-prostaglandin J2-glycerol ester, a putative metabolite of 2-arachidonyl glycerol, activates peroxisome proliferator activated receptor gamma. 2011 Mol. Pharmacol. pmid:21511917
Leamy AW et al. Curcumin ((E,E)-1,7-bis(4-hydroxy-3-methoxyphenyl)-1,6-heptadiene-3,5-dione) activates and desensitizes the nociceptor ion channel TRPA1. 2011 Neurosci. Lett. pmid:21855605
Lin TH et al. 15-deoxy-Δ(12,14) -prostaglandin-J2 and ciglitazone inhibit TNF-α-induced matrix metalloproteinase 13 production via the antagonism of NF-κB activation in human synovial fibroblasts. 2011 J. Cell. Physiol. pmid:21344384
Zheng S et al. Novel biphasic role of LipoxinA(4) on expression of cyclooxygenase-2 in lipopolysaccharide-stimulated lung fibroblasts. 2011 Mediators Inflamm. pmid:21765620
Hernandez JM and Janssen LJ Thromboxane prostanoid receptor activation amplifies airway stretch-activated contractions assessed in perfused intact bovine bronchial segments. 2011 J. Pharmacol. Exp. Ther. pmid:21768224
Tanaka A et al. Mast cells function as an alternative modulator of adipogenesis through 15-deoxy-delta-12, 14-prostaglandin J2. 2011 Am. J. Physiol., Cell Physiol. pmid:21865589
Bräutigam K et al. Combined treatment with TRAIL and PPARγ ligands overcomes chemoresistance of ovarian cancer cell lines. 2011 J. Cancer Res. Clin. Oncol. pmid:20878528
Alves C et al. Effects of 15d-PGJâ‚‚-loaded poly(D,L-lactide-co-glycolide) nanocapsules on inflammation. 2011 Br. J. Pharmacol. pmid:20883476
Kanda N et al. The antimycotic drugs itraconazole and terbinafine hydrochloride induce the production of human β-defensin-3 in human keratinocytes. 2011 Immunobiology pmid:20875690
Liu H et al. Modification of ubiquitin-C-terminal hydrolase-L1 by cyclopentenone prostaglandins exacerbates hypoxic injury. 2011 Neurobiol. Dis. pmid:20933087
Moniot B et al. Hematopoietic prostaglandin D synthase (H-Pgds) is expressed in the early embryonic gonad and participates to the initial nuclear translocation of the SOX9 protein. 2011 Dev. Dyn. pmid:21887724
Hewson CA et al. A differential role for ceramide kinase in antigen/FcɛRI-mediated mast cell activation and function. 2011 Clin. Exp. Allergy pmid:21255156
Kanai Y et al. Identification of novel oxidized levuglandin D2 in marine red alga and mouse tissue. 2011 J. Lipid Res. pmid:21893678
He P et al. Oxidative stress suppresses cysteinyl leukotriene generation by mouse bone marrow-derived mast cells. 2011 J. Biol. Chem. pmid:21233206
Tao H and Hajri T Very low density lipoprotein receptor promotes adipocyte differentiation and mediates the proadipogenic effect of peroxisome proliferator-activated receptor gamma agonists. 2011 Biochem. Pharmacol. pmid:21924248
Kitz K et al. 15-Deoxy-Δ12,14-prostaglandin J2 induces Cox-2 expression in human osteosarcoma cells through MAPK and EGFR activation involving reactive oxygen species. 2011 Free Radic. Biol. Med. pmid:21236332
Hossain MS et al. Development of enzyme-linked immunosorbent assay for Δ12-prostaglandin J2 and its application to the measurement of the endogenous product generated by cultured adipocytes during the maturation phase. 2011 Prostaglandins Other Lipid Mediat. pmid:21237281
De Nuccio C et al. Peroxisome proliferator-activated receptor γ agonists accelerate oligodendrocyte maturation and influence mitochondrial functions and oscillatory Ca(2+) waves. 2011 J. Neuropathol. Exp. Neurol. pmid:21937914
Choi YH et al. The extracellular signal-regulated kinase mitogen-activated protein kinase/ribosomal S6 protein kinase 1 cascade phosphorylates cAMP response element-binding protein to induce MUC5B gene expression via D-prostanoid receptor signaling. 2011 J. Biol. Chem. pmid:21832046
Aung G et al. Catestatin, a neuroendocrine antimicrobial peptide, induces human mast cell migration, degranulation and production of cytokines and chemokines. 2011 Immunology pmid:21214543
Chowdhury AA et al. Sustained expression of lipocalin-type prostaglandin D synthase in the antisense direction positively regulates adipogenesis in cloned cultured preadipocytes. 2011 Biochem. Biophys. Res. Commun. pmid:21726533
Hovsepian E et al. Modulation of inflammatory response and parasitism by 15-Deoxy-Δ(12,14) prostaglandin J(2) in Trypanosoma cruzi-infected cardiomyocytes. 2011 Int. J. Parasitol. pmid:21215746
Song NY et al. Multidrug resistance-associated protein 1 mediates 15-deoxy-Δ(12,14)-prostaglandin J2-induced expression of glutamate cysteine ligase expression via Nrf2 signaling in human breast cancer cells. 2011 Chem. Res. Toxicol. pmid:21728338
Lotz C et al. Activation of peroxisome-proliferator-activated receptors α and γ mediates remote ischemic preconditioning against myocardial infarction in vivo. 2011 Exp. Biol. Med. (Maywood) pmid:21163821
Charles RL et al. Redox regulation of soluble epoxide hydrolase by 15-deoxy-delta-prostaglandin J2 controls coronary hypoxic vasodilation. 2011 Circ. Res. pmid:21164107
Eguchi M et al. Lipopolysaccharide induces proinflammatory cytokines and chemokines in experimental otitis media through the prostaglandin D2 receptor (DP)-dependent pathway. 2011 Clin. Exp. Immunol. pmid:21166666
Oh YC et al. Anti-allergic effects of sinomenine by inhibition of prostaglandin Dâ‚‚ and leukotriene Câ‚„ in mouse bone marrow-derived mast cells. 2011 Immunopharmacol Immunotoxicol pmid:21080779
Cichocka-Jarosz E et al. Serum tryptase level is a better predictor of systemic side effects than prostaglandin D2 metabolites during venom immunotherapy in children. 2011 J Investig Allergol Clin Immunol pmid:21721371
Nabe T et al. Inhibition of hematopoietic prostaglandin D synthase improves allergic nasal blockage in guinea pigs. 2011 Prostaglandins Other Lipid Mediat. pmid:21601002
Joos H et al. Single impact trauma in human early-stage osteoarthritic cartilage: implication of prostaglandin D2 but no additive effect of IL-1β on cell survival. 2011 Int. J. Mol. Med. pmid:21567074
Shao Z et al. Choroidal involution is a key component of oxygen-induced retinopathy. 2011 Invest. Ophthalmol. Vis. Sci. pmid:21546530
Ji Y et al. Nutrient-induced inflammation in the intestine. 2011 Curr Opin Clin Nutr Metab Care pmid:21587069
Jakob S and Lovell-Badge R Sex determination and the control of Sox9 expression in mammals. 2011 FEBS J. pmid:21281448
Hardy KD et al. Nonenzymatic free radical-catalyzed generation of 15-deoxy-Δ(12,14)-prostaglandin J₂-like compounds (deoxy-J₂-isoprostanes) in vivo. 2011 J. Lipid Res. pmid:20944061
Wang JJ and Mak OT Induction of apoptosis in non-small cell lung carcinoma A549 cells by PGDâ‚‚ metabolite, 15d-PGJâ‚‚. 2011 Cell Biol. Int. pmid:21999315
Seno T et al. 15-Deoxy-Δ¹²,¹⁴ prostaglandin J₂ reduces the formation of atherosclerotic lesions in apolipoprotein E knockout mice. 2011 PLoS ONE pmid:22003398
Matsushima Y et al. Distinct roles of prostaglandin D2 receptors in chronic skin inflammation. 2011 Mol. Immunol. pmid:21943706
Shinozawa T et al. Tetranor PGDM analyses for the amyotrophic lateral sclerosis: positive and simple diagnosis and evaluation of drug effect. 2011 Biochem. Biophys. Res. Commun. pmid:22027143
Chang MC et al. Antiplatelet effect by p-cresol, a uremic and environmental toxicant, is related to inhibition of reactive oxygen species, ERK/p38 signaling and thromboxane A2 production. 2011 Atherosclerosis pmid:21993412
de Jong E et al. Anticancer effects of 15d-prostaglandin-J2 in wild-type and doxorubicin-resistant ovarian cancer cells: novel actions on SIRT1 and HDAC. 2011 PLoS ONE pmid:21957481
Jin M et al. Anti-inflammatory activity of 6-hydroxy-2,7-dimethoxy-1,4-henanthraquinone from tuberous roots of yam (Dioscorea batatas) through inhibition of prostaglandin Dâ‚‚ and leukotriene Câ‚„ production in mouse bone marrow-derived mast cells. 2011 Arch. Pharm. Res. pmid:21975811
Urade Y and Hayaishi O Prostaglandin D2 and sleep/wake regulation. 2011 Sleep Med Rev pmid:22024172
Birbian N et al. No association of PTGDR -441C/T polymorphism with asthma in a North Indian population. 2011 Dis. Markers pmid:22182808
Wan CJ et al. [PPARgamma agonists against respiratory syncytial virus infection in vitro study]. 2011 Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi pmid:22734242
Wang P et al. Response of chondrocytes to shear stress: antagonistic effects of the binding partners Toll-like receptor 4 and caveolin-1. 2011 FASEB J. pmid:21715681
Ahmed SR et al. Prostaglandin D2 regulates CD4+ memory T cell trafficking across blood vascular endothelium and primes these cells for clearance across lymphatic endothelium. 2011 J. Immunol. pmid:21715691
Yu R et al. Competitive enzymatic interactions determine the relative amounts of prostaglandins E2 and D2. 2011 J. Pharmacol. Exp. Ther. pmid:21865441
Koyama J et al. Simultaneous determination of histamine and prostaglandin D2 using an LC-ESI-MS/MS method with positive/negative ion-switching ionization modes: application to the study of anti-allergic flavonoids on the degranulation of KU812 cells. 2011 Anal Bioanal Chem pmid:21725829
Chae HS and Chin YW Anti-allergic effect of lambertianic acid from Thuja orientalis in mouse bone marrow-derived mast cells. 2012 Immunopharmacol Immunotoxicol pmid:21854102
Miyawaki T et al. Combination of midazolam and a cyclooxygenase-2 inhibitor inhibits lipopolysaccharide-induced interleukin-6 production in human peripheral blood mononuclear cells. 2012 Immunopharmacol Immunotoxicol pmid:21854184
Kanakasabai S et al. PPARγ agonists promote oligodendrocyte differentiation of neural stem cells by modulating stemness and differentiation genes. 2012 PLoS ONE pmid:23185633
Kaneko K et al. Novel orexigenic pathway prostaglandin D2-NPY system--involvement in orally active orexigenic δ opioid peptide. 2012 Neuropeptides pmid:23141054
Springstead JR et al. Evidence for the importance of OxPAPC interaction with cysteines in regulating endothelial cell function. 2012 J. Lipid Res. pmid:22550136
Fredman G et al. Self-limited versus delayed resolution of acute inflammation: temporal regulation of pro-resolving mediators and microRNA. 2012 Sci Rep pmid:22957142
Matzkin ME et al. Exploring the cyclooxygenase 2 (COX2)/15d-Δ(12,14)PGJ(2) system in hamster Sertoli cells: regulation by FSH/testosterone and relevance to glucose uptake. 2012 Gen. Comp. Endocrinol. pmid:22974512
Myeku N et al. cAMP stimulates the ubiquitin/proteasome pathway in rat spinal cord neurons. 2012 Neurosci. Lett. pmid:22982149
Mechiche H et al. Prostanoid receptors involved in regulation of the beating rate of neonatal rat cardiomyocytes. 2012 PLoS ONE pmid:22984630
Cloutier A et al. The prostanoid 15-deoxy-Δ12,14-prostaglandin-j2 reduces lung inflammation and protects mice against lethal influenza infection. 2012 J. Infect. Dis. pmid:22219346
Sykes L et al. Changes in the Th1:Th2 cytokine bias in pregnancy and the effects of the anti-inflammatory cyclopentenone prostaglandin 15-deoxy-Δ(12,14)-prostaglandin J2. 2012 Mediators Inflamm. pmid:22690041
Raman P et al. 15-Deoxy-Δ¹²,¹⁴-prostaglandin J₂-glycerol, a putative metabolite of 2-arachidonyl glycerol and a peroxisome proliferator-activated receptor γ ligand, modulates nuclear factor of activated T cells. 2012 J. Pharmacol. Exp. Ther. pmid:22700433
Cao DS et al. Expression of transient receptor potential ankyrin 1 (TRPA1) and its role in insulin release from rat pancreatic beta cells. 2012 PLoS ONE pmid:22701540